ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 5th, 2016 • Retrophin, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 5th, 2016 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of June 9, 2016 (the “Effective Date”), by and between Retrophin, Inc., a Delaware corporation (“Retrophin” or “Buyer”) and Asklepion Pharmaceuticals, LLC, a Delaware limited liability company (“Asklepion” or “Seller”). Buyer and Seller may be referred to herein collectively as the “Parties” and individually as a “Party.”